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Sirs—In their study on women’s perception of the benefits
of mammography screening in four countries, Domenighetti
and colleagues found an overestimation of the benefits of
mammography screening.1 While every effort to tackle the
difficult but essential issue of balanced risk information in
health prevention is commendable, we have serious concern
about two aspects of this study, i.e. its design and conclusions.
Two of the three questions on which the study is based
addressed, respectively, the perceived relative (Q2) and absolute
(Q3) benefits of regular mammography screening. As the
wording of both questions suggests that mammography
screening reduces breast cancer mortality and the correct
answer is systematically the smallest positive effect among the
proposed answers, underestimation of the quantification of
the beneficial effect of mammography screening is virtually
impossible in this study.2
Further, the restriction to one correct or most appropriate
answer for Q2 and Q3 is also questionable. Reporting of the
impact of regular mammography screening on breast cancer
mortality ranges from none3,4 to about a 50% reduction.5,6
When, as is the case for mammography screening, disseminated
messages about the effect are heterogeneous, reflecting in part
the diverging opinions held by health professionals on the issue,
it is not surprising to observe comparable variations in the
perceived quantification of the benefits among the female
population. The complexity of Q3 may furthermore require a
particularly astute mind, from unprepared respondents, to work
out the mathematics behind it (trying this question on work
colleagues is informative in this respect).
Question 1, which highlights what screening cannot achieve
(primary prevention), with a misleading statement, further
emphasizes the crucial importance of wording and selection of
answers for closed questions, and the distorting effect that
apriorism can have on a study design.2 In the Swiss canton of
Vaud where organized screening has been offered to 50–69 year
old women for a decade,7 the question ‘What is the purpose of
mammography screening?’ was asked in two consecutive
random phone surveys of 50–69 year old females, with different
allowed answers. One objective was to assess the possible
confusion around the term prevention which was believed to be
understood by some as ‘prevents the development of a breast
cancer toward a fatal outcome’. When ‘to prevent cancer’ was a
proposed answer, a majority of respondents opted for this
choice with only 43% of females agreeing that mammography
screening enables detection of a lesion and the offer of a less-
aggressive treatment (data available on request). However, 93%
of respondents adequately stated that screening enables
detection of a breast anomaly when ‘to prevent cancer’ was
replaced by the probably less confusing ‘to avoid cancer’ (4% of
respondents elicited this answer) in the second survey
conducted about 4 months later. Adequate quantification of
current misconceptions about screening8 is necessary to assess
the effectiveness of future strategies aimed at improving public
understanding.
Conclusive criticisms of ‘ill informed’ procedures are
restricted to breast screening programmes, even though no data
on the source of screening information appear to have been
collected.1 Sensitization to regular mammography examination
generally occurs from several complementary partners, with
various incentives to do so. In the Vaud telephone survey, most
(59%) women were informed and sensitized about the
importance of breast screening by their treating physicians (GPs
or gynaecologists) with only 20% reporting the regional
screening programme as her source of information. Further,
having had a mammography in the last 2 years, whether for
screening or diagnostic purpose, is not an appropriate surrogate
for participation in organized screening programmes.
While these ‘ill formulated’ questions cannot adequately
measure women’s perception of the benefits of mammography
screening, as might have simpler, open-ended questions, they
nevertheless enable two observations to be made: (1) An
overwhelming majority of women knew and agreed with a
beneficial effect of repeated mammography screening (5% stated
that regular mammography screening hardly reduces breast
cancer deaths, Q2). (2) The lay public remains confused in
appreciating absolute versus relative risks, and these statistics need
to be demystified. In our increasingly risk conscious society, valid
studies are urgently needed to further elaborate how risk
information can be conveyed simply and objectively for improving
presentation and content of mammography screening messages,9
so that women could make informed, autonomous choices.
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We thank Bulliard and Levi for their interest in our
international population-based survey of women’s perception
of the benefits of mammography screening.1,2 Our survey
showed that in the US and three European countries (UK,
Italy, Switzerland) a high proportion of women overestimated
the benefits that can be expected from screening
mammography.
Bulliard and Levi argue that the questions used in our survey
could not adequately measure perceptions and that simpler,
open-ended questions should have been used. Survey questions
can always be improved, particularly in the light of answers
received, but we do not think that the use of open-ended
questions would have led to different conclusions. For example,
even when classifying the answer that biannual screening in
women older than 50 years reduces breast cancer mortality ‘by
about half’ as correct, 20% (Switzerland) to 38% (US) of
women would overestimate benefits (Table 1 in ref. 2). These
findings are in line with the results of a survey in the Canton of
Geneva conducted in 1998.3
Bulliard and Levi believe that the wording of the question on
whether screening ‘prevents’ or ‘reduces’ the risk of contracting
breast cancer may have been misunderstood and that using
the phrase ‘avoids breast cancer’ would have yielded more
appropriate responses. It is clear that the wording of closed
questions can affect responses4 but the change suggested by
Bulliard and Levi is subtle and unlikely to be of great
importance. The question was asked in four different languages
(English, Italian, German, French) and the frequency with
which women erroneously chose to answer that ‘regular
mammography prevents’ or ‘reduces the risk of breast cancer’
was above 50% in all countries. We think that a more plausible
explanation for these results is the quality of the information
that is disseminated on mammography screening. For example,
an analysis of the contents of leaflets in Australia revealed a
worrying emphasis on cancer incidence, despite the fact that the
incidence of breast cancer is not reduced by screening.5 Similar
results were recently obtained by Jørgensen and Gøtzsche who
investigated relevant websites in Scandinavian and English
speaking countries with national breast cancer screening
programmes.6
Finally, Buillard and Levi disagree with the conclusion that
our results ‘raise doubt on informed consent procedures within
mammography screening programmes’. We agree with Buillard
and Levi that women’s perception will be shaped by several
sources of information, and we acknowledge that we did
not ask about these sources. Nevertheless, women with
misconceptions about mammography who participate in breast
cancer screening programmes may well have given consent that
is not truly informed. Interestingly, the number of correct
answers among British women aged 50–59 (the women in
our study with access to a national screening programme) was
lower compared with women from Switzerland and the US,
where opportunistic screening dominates. In Switzerland, when
using the same question in a survey of women aged 50–69
living in the Morges district of the Canton of Vaud, where a pilot
breast cancer screening programme has been in place since
1995, 80% of respondents believed that that regular
mammography reduces or prevents breast cancer7 compared
with 65% in the national survey.2 These findings may reflect
the dilemma that organized screening programmes face when
attempting both to achieve high coverage and to provide
balanced information.8 Indeed, the quality and the extent of the
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